Slide Lecture: Therapeutic benefit of baseline PSA: Lower baseline PSA is associated with a greater overall survival benefit from sipuleucel-T in the Immunotherapy for Prostate Adenocarcinoma Treatment (IMPACT) trial

BERKELEY, CA USA (UroToday.com) - Presented by Leonard Gomella, MD, Clinical Director Jefferson Kimmel Cancer Center Network, Philadelphia, PA USA

Leonard Gomella, MD is the Bernard W. Godwin Professor of Prostate Cancer; Chairman, Department of Urology; Clinical Director Jefferson Kimmel Cancer Center Network; Philadelphia, PA USA.

 

 

E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe